Literature DB >> 8635971

Clinical, hematologic, and biochemical features of a syndrome in Bernese mountain dogs characterized by hepatocerebellar degeneration.

K P Carmichael1, M Miller, C A Rawlings, A Fischer, J E Oliver, B E Miller.   

Abstract

Seven related Bernese Mountain Dogs developed a syndrome Characterized by progressive cerebellar and hepatic disease. Clinically, stiffness in the hind limbs, mild incoordination, and a slight head tremor were first noticeable when pups were 4 to 6 weeks old. The condition progressed, causing pups to assume a wide-based stance. Other signs included head bobbing, spontaneous nystagmus, and, finally, paresis. Hematologic findings included leukocytosis with a left shift; normocytic, normochromic anemia; hypoproteinemia, low serum creatinine, and urea nitrogen concentrations; excessive fasting plasma ammonia concentration; and an increase in concentration of serum bile acids. Portal venography performed on 1 dog revealed a small liver and extensive extrahepatic varicosities. Necropsy revealed cerebellar hypoplasia, nodular liver, extensive abdominal varicosities, and ascites. Histologically, degeneration and depletion of Purkinje's cells and vacuolation, degeneration, and nodular regeneration of hepatic tissues were evident. Preliminary analysis of the pedigree was suggestive of an autosomal recessive pattern of inheritance.

Entities:  

Mesh:

Year:  1996        PMID: 8635971

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Late onset of cerebellar abiotrophy in a boxer dog.

Authors:  Sanjeev Gumber; Doo-Youn Cho; Timothy W Morgan
Journal:  Vet Med Int       Date:  2010-12-05

2.  A SEL1L mutation links a canine progressive early-onset cerebellar ataxia to the endoplasmic reticulum-associated protein degradation (ERAD) machinery.

Authors:  Kaisa Kyöstilä; Sigitas Cizinauskas; Eija H Seppälä; Esko Suhonen; Janis Jeserevics; Antti Sukura; Pernilla Syrjä; Hannes Lohi
Journal:  PLoS Genet       Date:  2012-06-14       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.